: Pulpal Blood Flow With the Use of Intra-nasal Anesthetic

NCT03368391 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Local Anesthetic Drug Adverse Reaction
Local Infiltration
Pulp Disease, Dental

Interventions

DRUG: tetracaine HCl and oxymetazoline HCL
DRUG: 2% Lidocaine with 1:100,000 epinephrine
DRUG: 3% Mepivacaine with 1:100,000 epinephrine
DRUG: saline intranasal
DRUG: saline infiltration

Sponsor

Louisiana State University Health Sciences Center in New Orleans